0
0
0
Mandatory End to Needle Distribution in Our Neighborhoods Act
2/8/2022, 11:40 PM
Congressional Summary of HR 7407
Mandatory End to Needle Distribution in Our Neighborhoods Act
This bill prohibits the Department of Health and Human Services and the Centers for Disease Control and Prevention from using federal funds to support needle exchange or syringe exchange programs.
Historically, language in appropriations bills prohibited federal funds from being used to support these programs. However, the Consolidated Appropriations Act of 2018 authorized federal support for them under certain circumstances, provided no funds are used to purchase needles or syringes.
Read the Full Bill
Current Status of Bill HR 7407
Bill HR 7407 is currently in the status of Bill Introduced since June 29, 2020. Bill HR 7407 was introduced during Congress 116 and was introduced to the House on June 29, 2020. Bill HR 7407's most recent activity was Referred to the House Committee on Energy and Commerce. as of June 29, 2020
Bipartisan Support of Bill HR 7407
Total Number of Sponsors
1Democrat Sponsors
0Republican Sponsors
1Unaffiliated Sponsors
0Total Number of Cosponsors
0Democrat Cosponsors
0Republican Cosponsors
0Unaffiliated Cosponsors
0Policy Area and Potential Impact of Bill HR 7407
Primary Policy Focus
HealthPotential Impact Areas
- Drug trafficking and controlled substances
- Drug, alcohol, tobacco use
- Executive agency funding and structure
- Health programs administration and funding
- Health technology, devices, supplies
Alternate Title(s) of Bill HR 7407
Mandatory End to Needle Distribution in Our Neighborhoods Act
To prohibit the use of Federal funds to carry out or support a program that distributes hypodermic needles or syringes.
Mandatory End to Needle Distribution in Our Neighborhoods Act
Comments
Sponsors and Cosponsors of HR 7407
Latest Bills
Strengthening America’s Turning Point Act
Bill S 1518July 26, 2026
Unlocking Native Lands and Opportunities for Commerce and Key Economic Developments Act of 2025
Bill S 3383July 25, 2026
To amend the Research and Development, Competition, and Innovation Act to support nucleic acid screening, and for other purposes.
Bill HR 3029July 25, 2026
Transparency in Billing Act of 2026
Bill HR 8684July 25, 2026
Accelerating Access to Critical Therapies for ALS Reauthorization Act of 2026
Bill S 4472July 25, 2026
Connected Vehicle Security Act of 2026
Bill S 4429July 25, 2026
Protecting American Taxpayers Act
Bill S 4952July 25, 2026
National Defense Authorization Act for Fiscal Year 2027
Bill S 4784July 25, 2026
Renewing the African American Civil Rights Network Act
Bill S 4767July 25, 2026
National Plan for Epilepsy Act
Bill S 494July 25, 2026
